久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

美國 Singulex   
一種信息生物分析系統能夠檢測血液中的心臟肌鈣蛋白I(cTnI)。cTnI是已知的心肌損害的生物醫學標志物。

這種新型檢測方法叫做Erenna，業已證實其診斷能力符合新近重新定義的急性心肌梗塞(AMI)診斷標準，已經得到了歐洲心臟學會和美國心臟學會的重視和推薦。

這種Erenna檢測方法是由Singulex公司(Haywood, CA, USA)研制開發的，使用了獲得專利的直接單分子檢測技術以及用戶自定義的臨床檢測方法，能夠在亞皮克(pg)水平定量檢測具有治療意義的生物標志物。研究顯示Erenna能夠顯著降低樣本背景，能夠鑒別檢測來自其他分子的染料，檢測結果具有良好的可重復性和較好的信/噪比。

Singulex enables critical research about disease and therapeutic intervention by providing cutting edge immunodiagnostic products and personalized services.

Singulex, Inc. has pioneered single-molecule counting technology that can quantitatively measure single molecules such as proteins and metabolites directly in complex biological samples without abundant protein stripping techniques. We provide instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy.

In addition, we focus on advancing industry-leading sample analysis and custom assay development services. Our team of scientists are experts in the field of immunoassay development and our manufacturing department ensures that products are produced with the highest standards.

Leveraging upon the Singulex technology, our CVMedHome Offering empowers physicians and patients to better manage heart health with a unique cardiovascular wellness management program. The CVMedHome offering includes enhanced cardiovascular profiling services featuring ultrasensitive Sgx HD? immunoassays, a personalized wellness program, and online interactive management tools.